Navidea Biopharmaceuticals Inc (NYSE MKT LLC:NAVB)

1.62
Delayed Data
As of Feb 27
 -0.05 / -2.99%
Today’s Change
0.97
Today|||52-Week Range
2.12
-14.29%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2010

2011

2012

2013
Revenue and IncomeNet Revenues10.7M597.7K78.7K1.1M
 
 
 
 
 
Cost of Goods Sold3.0M----332.8K
 
 
 
Depreciation And Amortization223.5K176.5K200.2K404.2K
 
 
 
 
 
 
Operating ExpensesGross Income7.5M----393.6K
 
 
 
General Expenses13.8M24.5M27.9M38.8M
 
 
 
 
 
Research And Development9.2M15.2M16.9M23.7M
 
 
 
 
 
Total Operating Expenses17.0M24.7M28.1M39.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-6.3M-24.1M-28.0M-38.4M
 
 
 
 
 
Extraordinary Credit0.000.0032.1K0.00
 
 
Extraordinary Charge-43.1M-952.4K---1.5M
 
 
 
 
Interest Expense On Debt555.0K13.3K1.2M2.8M
 
 
 
 
 
Other Expenses32.6K-3.2K-58.7K-16.9K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-49.9M-25.0M-29.2M-42.7M
 
 
 
 
 
Income Taxes0.00-7.9M0.000.00
 
 
Preferred Dividend-8.2M-100.0K-43.3K0.00
 
 
 
 
Discontinued Operations-86.6K3.3M0.000.00
 
 
 
Extraordinary Items0.0019.5M0.000.00
 
 
Net Income-50.0M-13.8M-29.2M-42.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS80.7M90.5M99.1M121.8M
 
 
 
 
 
Shares To Calculate EPS Diluted80.7M90.5M99.1M121.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.72$0.06-$0.29-$0.35
 
 
 
 
 
EPS Diluted-$0.72-$0.15-$0.29-$0.35
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account